Chronic Kidney Disease

Factors Predict Response to Epoetin

Older age, elevated BMI, and use of ACE inhibitors and/or angiotensin receptor blockers (ARBs) are associated with increased epoetin requirements when normalizing blood hemoglobin levels in CKD patients.

CERA Outcomes Promising

ORLANDO—Continuous erythropoietin receptor activator (CERA) corrects and maintains hemoglobin (Hb) levels at least as well as erythropoiesis-stimulating agents in patients with CKD anemia, recent studies suggest.

Primary Screening in Renal Patients

The medical care care of patients with renal disease includes notonly disease-specific care but preventive and general care as well as the treatment of minor acute illnesses, according to Kevin M. Fosnocht, MD, clinical assistant professor of medicine at the University of Pennsylvania School of Medicine in Philadelphia.

One in 10 Have An ESRD History

Nearly 10% of U.S. adults have a family history of end-stage renal disease (ESRD), and these individuals may be at increased risk of developing kidney disease themselves, a study says.

Taking Fewer Lanthanum Carbonate Pills

SAN DIEGO—Doses of lanthanum carbonate as high as 4,500 mg a day appear to be well tolerated and may provide serum phosphorus control for some stage-5 CKD patients who do not respond to 3,000 mg a day, according to a new trial of patients on maintenance hemodialysis.

Next post in News